Moody's Adjusts Outlook on Elan (ELN) from Stablet to Developing; Affirms Ratings
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 8/21/2026
- Wall St indexes eye weekly losses; bond yields and Iran in focus
- UBS says bull market has further to run
- S&P 500 may pull back before midterms, but Citi says buy the dip
- Global yield relief evaporates as U.S. rates push back toward multi-decade peaks
- BofA's Hartnett sees dollar slump, risk selloff if bond intervention fails
- Wall Street sinks as bond yields rise, Walmart results disappoint
- Fannie Mae loses at least 10 senior executives amid departures - WSJ
- Supermicro probe finds no senior management link to export violations
- Wolfe remains "broadly bullish on AI semis stocks", names Top Pick
- Hertz Global amends voting agreement with CK Amarillo after lawsuit
Elan Corp (ELN) Could Be Worth $19 in a Takeout - Jefferies
June 18, 2013 7:11 AM EDTJefferies boosted its price target dramatically on takeover target Elan Corp (NYSE: ELN) from $14 to $19, while reiterating their Buy rating. The firm seeks to answer the 4 main questions on the minds of investors: (1) Who is going to buy ELN? (2) What is the price? (3) How long will the process take? and (4) Will a transaction actually get done?
Analyst Corey Davis comments:
"On Friday, management indicated that they had received "expressions of interest" in a potential acquisition of the company and... More
Royalty Pharma Calls News of Elan (ELN) Sales Process 'Frustrating Tactic'
June 14, 2013 1:40 PM EDTRoyalty Pharma notes today's announcement by Elan Corporation, plc (NYSE: ELN) that it intends to explore a sale of the Company. Royalty Pharma believes it to be a clear frustrating tactic that offers shareholders no certainty that a deal will ever be reached. Royalty Pharma calls on holders of ordinary shares to vote today AGAINST all four resolutions... More
Elan Corp. (ELN) to Proceed with Sale; Invites Royalty Pharma to Participate
June 14, 2013 9:17 AM EDTElan Corporation, plc (NYSE: ELN) (Elan or the Company) today announced that it is proceeding with a formal sale process in light of the expressions of interest received to date. As part of this process, Royalty Pharma will be invited to participate if they so... More
